Next, the performance of this method was further evaluated using the lung cancer cell lines and the EGFR L858R mutant statuses were identified using the 10 ng genomic DNA extracted from the NCI-H1975 and A549 cell lines, respectively. This evidence concerns the gene EGFR and lung carcinoma.